Ambulatory Arrhythmia Monitoring Devices Market Report and Forecast 2025-2034

The global ambulatory arrhythmia monitoring devices market is expected to grow at a CAGR of 6.80% during the period 2025-2034.

Focus on Early Disease Detection and Prevention, Desire for Improved Quality of Life, and Technologically Superior Devices Expected to Drive the Market

Advancements in wearable technologies have offered new ways to diagnose and manage cardiovascular diseases and associated risk factors. Common technologies include heart rate, rhythm and blood pressure monitoring devices which are available to consumers directly. With time, wearable devices have become more sophisticated and their capacity to diagnose cardiovascular diseases and risk factors has enhanced. The direct-to-consumer healthcare sector is steadily growing, USA being the key market. With advancements in technology and introduction of new wearable devices, the wearable device sector is expected to expand further.

In Europe, coronary heart disease (CHD) is the leading cause of death. In America also, chronic heart disease is a major contributor to the number of deaths. At the same time, the number of people living with heart disease or those who have survived major cardiac attacks is rising. These numbers, however, may be linked to advancements made in diagnostic and monitoring capabilities that have become available to patients.

With an ageing global population, increasing focus on prevention and early recognition of disease, and desire for improved quality of life, the demand for ambulatory arrhythmia monitoring devices is expected to increase.

Ambulatory heart monitoring might prove to be an efficient way to evaluate and monitor individuals experiencing symptoms of cardiac arrhythmia, such as syncope, palpitations and dizziness. The method of monitoring would depend on frequency and intensity of symptoms.

At present, many devices are employed to evaluate cardiac rhythm abnormalities in ambulatory patients. These include pre-symptom continuous-loop or post-symptom recorders that can be worn externally or implanted into the body. Advancements in continuous real-time remote cardiac monitoring have enabled improved diagnosis.

Leading companies are looking to expand their capacities through mergers and acquisitions to offer efficient diagnostic solutions.

Patient-and-Event-Activated Intermittent Recorders

These devices are capable of consistently monitoring a patient’s ECG without constantly recording the data. Recorded data may be sent to a doctor or hospital through telephone or uploaded to a computer. Monitoring could be performed for months or weeks.

External Loop Recorders, Pre-symptom Memory Loop Cardiac Event Recorders

These can be worn for twenty to thirty days. The recorders employ memory loop recording (recording multiple minutes of activity at a given time and then begin again). When an individual experiences symptoms, they hold the device next to their chest and activate the device which then records ECG data. Only symptomatic events are recorded, enabling the doctor to decide if the symptoms are caused by cardiac arrhythmia.

Auto-trigger External Loop Recorders

These employ memory-loop recording, but record asymptomatic as well as symptomatic events.

Implantable or Insertable Loop Recorders, Pre-symptom Memory Loop Cardiac Event Recorders

These devices are implanted subcutaneously in the left or right side of the chest, and can be used for nearly fourteen to twenty months before being surgically removed.

Post-symptom Event Recorders

These are hand-held devices which require to be placed on the precordium when symptoms take place to record some minutes of ECG data.

Continuous Realtime Attended Remote Cardiac Monitors

These automatically record and send event data to the attendant at the hospital.

Mobile Cardiac Outpatient Telemetry System (CardioNet)

This system automatically detects and sends ECG data (through a sensor worn around the neck or on the belt) when an arrhythmic event happens. Individuals using this device are assessed for up to twenty-one days.

Remote Event Monitor (REM)

The REM is made of a flexible three-lead ECG electrode patch, a body-worn device and a hand-held/belt-worn device. The electrode enables continuous ECG monitoring through the attached body-worn device for up to 7 days. The patient may press an ‘event’ button on the monitor if they experience symptoms. The body-worn device employs memory loop recording to record the patient’s ECG before, during and after the event.

A short-range wireless link transmits data to the hand-held device which utilizes wireless technology (like GPRS or WiFi) to send the ECG data to a receiving station. REM enables asymptomatic events to be recorded and transmitted, and includes several arrhythmia detection algorithms in the on-board software. REM system allows individuals to perform normal daily activities during the assessment period.

Ambulatory Arrhythmia Monitoring Devices Definition and Global Market Segmentation

Ambulatory arrhythmia monitoring devices are used to detect and determine heart arrhythmia occurring unpredictably. Symptoms produced by arrhythmia are generally sudden and last for a short time. Thus, by the time the individual experiencing symptoms reaches the doctor, the symptoms may no longer be present, making it difficult to diagnose arrhythmia. In such cases, ambulatory monitoring devices are favoured. These devices are capable of monitoring heart activity for longer periods of time, increasing the chances of discovering the incidence of arrhythmia during the assessment period.

By device type, the market is segmented into:

• Resting ECG
• Event Monitor
• Implantable Cardiac Monitor
• Holter Monitor
• Mobile Cardiac Telemetry Devices
• Others

By end-user, the market is classified according to:

• Hospitals and Clinics
• Diagnostic Centres
• Ambulatory Surgical Centres
• Homecare Settings
• Others

By region, the market is segmented into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Key Industry Players in the Global Ambulatory Arrhythmia Monitoring Devices Market

The report presents a detailed analysis of the following key players in the market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Biotronik
• BioTelemetry Inc.
• Abbott Laboratories
• Medi-Lynx Cardiac Monitoring, LLC
• ZOLL Medical Corporation
• Others

The report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.